Siegfried Holding Liabilities 2024

Siegfried Holding Aktienanalyse

What does Siegfried Holding do?

The Siegfried Holding AG is a Swiss pharmaceutical company based in Zofingen, which operates worldwide. The company's history dates back to 1873, when the pharmacist and chemist Franz von Siegfried founded the "First Aid Pharmacy". Over the years, the company has developed into an important producer of pharmaceutical ingredients. The business model of Siegfried Holding AG is based on the production and distribution of pharmaceutical ingredients, intermediate products, and finished products. The products are used in various areas, such as veterinary medicine, human medicine, or the chemical industry. Siegfried operates various divisions that focus on different segments of the value chain. These divisions include production, contract development and manufacturing (CDMO), and commercial products. In the production division, the company produces pharmaceutical ingredients and intermediate products. The CDMO business offers custom development and manufacturing services for the pharmaceutical and biotech industry. In the commercial products division, finished products such as cough medicine, antidepressants, or blood pressure reducers are distributed. Among the products offered by Siegfried are the active ingredient carbamazepine, which is used as an anticonvulsant and for the treatment of bipolar disorder. Another active ingredient is acetaminophen, which is used as a painkiller and fever reducer. Siegfried also produces the active ingredient sotalol, which is used to treat heart rhythm disorders. In the context of the CDMO business, Siegfried also develops and produces custom products for the pharmaceutical and biotech industry. This includes the manufacturing of clinical trial preparations, the implementation of process developments, and scale-up productions of active ingredients and finished products. In recent years, Siegfried Holding AG has made several acquisitions to expand its business and strengthen its market presence. In 2016, the company acquired Bexbach-based Saltigo GmbH, a specialist in the production of customer-specific fine chemicals. Two years later, Siegfried acquired the active ingredient production business of Alcami, a US pharmaceutical company. In summary, it can be said that Siegfried Holding AG is an established Swiss pharmaceutical company specializing in the production and distribution of pharmaceutical ingredients, intermediate products, and finished products. In recent years, the company has made several acquisitions to expand its market presence and diversify its business. Siegfried Holding ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Siegfried Holding's Liabilities

Siegfried Holding's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Siegfried Holding's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Siegfried Holding's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Siegfried Holding's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Siegfried Holding’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Siegfried Holding Stock

What is the level of liabilities of Siegfried Holding this year?

Siegfried Holding has a debt balance of 1.02 B CHF this year.

What were the liabilities of Siegfried Holding compared to the previous year?

The liabilities of Siegfried Holding have increased by 2.09% increased compared to the previous year.

What are the consequences of high debt for investors of Siegfried Holding?

High liabilities can pose a risk for investors of Siegfried Holding, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Siegfried Holding?

Low liabilities mean that Siegfried Holding has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Siegfried Holding affect the company?

An increase in liabilities of Siegfried Holding can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Siegfried Holding affect the company?

A decrease in the liabilities of Siegfried Holding can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Siegfried Holding?

Some factors that can influence the liabilities of Siegfried Holding include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Siegfried Holding so important for investors?

The liabilities of Siegfried Holding are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Siegfried Holding take to modify the liabilities?

To change its liabilities, Siegfried Holding can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Siegfried Holding pay?

Over the past 12 months, Siegfried Holding paid a dividend of 3.4 CHF . This corresponds to a dividend yield of about 0.4 %. For the coming 12 months, Siegfried Holding is expected to pay a dividend of 3.99 CHF.

What is the dividend yield of Siegfried Holding?

The current dividend yield of Siegfried Holding is 0.4 %.

When does Siegfried Holding pay dividends?

Siegfried Holding pays a quarterly dividend. This is distributed in the months of August, July, June, June.

How secure is the dividend of Siegfried Holding?

Siegfried Holding paid dividends every year for the past 0 years.

What is the dividend of Siegfried Holding?

For the upcoming 12 months, dividends amounting to 3.99 CHF are expected. This corresponds to a dividend yield of 0.46 %.

In which sector is Siegfried Holding located?

Siegfried Holding is assigned to the 'Health' sector.

Wann musste ich die Aktien von Siegfried Holding kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Siegfried Holding from 5/7/2024 amounting to 3.6 CHF, you needed to have the stock in your portfolio before the ex-date on 5/3/2024.

When did Siegfried Holding pay the last dividend?

The last dividend was paid out on 5/7/2024.

What was the dividend of Siegfried Holding in the year 2023?

In the year 2023, Siegfried Holding distributed 3.2 CHF as dividends.

In which currency does Siegfried Holding pay out the dividend?

The dividends of Siegfried Holding are distributed in CHF.